Benefits include reduced radiation exposure, fewer adverse reactions, higher image quality, and better detection of malignant features.

Earlier analyses demonstrated strong local tumor control, with nearly nine in 10 patients remaining free of recurrence at ...

This 21st-century centre of cutting-edge science is also a medieval site of celestial auguries, of miracle cures performed and witnessed ...

Full-body MRIs are all the rage. We take a look at three major companies offering such testing.

Artificial intelligence (AI) has become an indispensable tool in Estonian hospitals, aiding both stroke and radiation therapy treatment while saving doctors hours of valuable time. At the same time, ...

At-home diagnostic tests could cut wait times, easing pressure on Canada's health-care system and enhancing patient outcomes.

Breta Hasimi struggled to speak when she received the diagnosis of triple-negative breast cancer, one of the most aggressive ...

Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of recurrence after surgery showed significantly improved disease-free survival when ...

At 24 months overall survival was 62.8% with Welireg plus Lenvima versus 55.4% with Cabometyx. Median overall survival was 34 ...

According to Tang, this independence suggests that each biomarker provides unique prognostic information, making both valuable for understanding patient outcomes. Building on these findings, the ...

Findings presented at the 2026 ASCO GU Symposium show that combinatorial therapies may provide new treatment options for patients with renal cell carcinoma or muscle-invasive bladder cancer.

Clinical node involvement on preoperative PSMA-PET predicts radiographic recurrence for pN1 prostate cancer patients following RP/PLND.